BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 11592052)

  • 1. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
    Su Q; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.
    Krasnianski M; Eger K; Neudecker S; Jakubiczka S; Zierz S
    Arch Neurol; 2003 Oct; 60(10):1421-5. PubMed ID: 14568813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Facioscapuloperoneal muscular dystrophy: correlation between a phenotype and genotype].
    Rudenko DI; Kazakov BM; Skoromets AA; Magomedova NK
    Patol Fiziol Eksp Ter; 2009; (2):22-7. PubMed ID: 19537084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene diagnosis of facioscapulohumeral muscular dystrophy].
    Zhang JL; Shen DG; Zhou PK; Liu JW; Jia N; Liu H; Wang HB; Yang SX; Frants RR
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Jun; 20(3):232-4. PubMed ID: 12778451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic analysis of facioscapulohumeral muscular dystrophy (FSHD)].
    Goto K; Song MD; Lee JH; Arahata K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1416-8. PubMed ID: 8752415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD).
    van der Maarel SM; Deidda G; Lemmers RJ; Bakker E; van der Wielen MJ; Sandkuijl L; Hewitt JE; Padberg GW; Frants RR
    J Med Genet; 1999 Nov; 36(11):823-8. PubMed ID: 10544225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
    Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
    Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FSHD-like patients without 4q35 deletion.
    Yamanaka G; Goto K; Ishihara T; Oya Y; Miyajima T; Hoshika A; Nishino I; Hayashi YK
    J Neurol Sci; 2004 Apr; 219(1-2):89-93. PubMed ID: 15050443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of facioscapulohumeral muscular dystrophy (FSHD).
    Fisher J; Upadhyaya M
    Neuromuscul Disord; 1997 Jan; 7(1):55-62. PubMed ID: 9132141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facioscapulohumeral dystrophy.
    Kissel JT
    Semin Neurol; 1999; 19(1):35-43. PubMed ID: 10711987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Facioscapulohumeral muscular dystrophy (FSHD)].
    Funakoshi M; Goto K; Kim BY; Arahata K
    Nihon Rinsho; 1997 Dec; 55(12):3181-5. PubMed ID: 9436432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
    Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
    J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
    Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
    J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
    Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M
    Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Translocation between chromosomes 4q35 and 10q26 in facioscapulohumeral muscular dystrophy].
    Su QX; Zhang C; Zeng Y; Lu XL; Liu XR; Wang ZH; Zhu YZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):581-4. PubMed ID: 14650163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of the Bgl II-Bln I dosage test to gene diagnosis of facioscapulohumeral muscular dystrophy 1A gene].
    Su QX; Zhang C; Xie YM; Zeng Y; Liu XR; Lu XL; Zhu YZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):245-7. PubMed ID: 15192827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.